Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 11.45
+0.02 (0.17%)
Apr 29, 2026, 3:04 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 4.78 billion as of April 29, 2026. Its market cap has decreased by -12.66% in one year.
Market Cap
4.78B
Enterprise Value
3.24B
Revenue
459.02M
Ranking
n/a
PE Ratio
143.13
Stock Price
11.45
Market Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 4.78B, a decrease of -46.62%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.78B | -6.30% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition